Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 diciembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Clinical, angiographic, and intravascular ultrasound results of the VestSaync II trial

J. Ribamar Costa Jr MD1, Breno A. Oliveira MD2, Alexandre Abizaid MD1,*, Ricardo Costa MD1, Marco Perin MD2, Andréa Abizaid MD1, Daniel Chamié MD1, Luiz Fernando Tanajura MD1, Amanda Sousa MD1 andJ. Eduardo M.R. Sousa MD1

Aim: We sought to assess the long term efficacy of the novel VESTAsync™ Eluting Stent (VES) combining a Cro-Co platform with a nanothin-microporous hydroxyapatite surface coating impregnated with a polymer-free low-dose of Sirolimus (55 μg).

01 diciembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Incidence of adverse cardiac events 5 years after polymer-free sirolimus eluting stent implantation: Results from the prospective Bad Berka Yukon Choice™ registry

Marc-Alexander Ohlow MD1,*, Hubertus von Korn MD2, Oliver Gunkel MD3, Ahmed Farah MD1, Joerg T. Fuhrmann MD1 andBernward Lauer PhD1

Objectives: Drug-eluting stents (DES) constitute a major achievement in preventing re-stenosis, concerns remain regarding the increased inflammatory responses associated with the polymers used. This analysis focuses on outcomes in patients receiving the polymer-free sirolimus-eluting stent system YUKON-Choice (Yukon-DES, Translumina, Germany).

01 diciembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Amplatzer left atrial appendage occlusion through a patent foramen ovale

Dezsoe Koermendy MD†, Fabian Nietlispach MD†, Samera Shakir MD, Steffen Gloekler MD, Peter Wenaweser MD, Stephan Windecker MD, Ahmed A. Khattab MD andBernhard Meier MD*

Objectives: To assess feasibility and outcomes of left atrial appendage (LAA) closure when using a patent foramen ovale (PFO) for left atrial access. Background: Because of the fear of entering the left atrium too high, using a PFO for left atrial access during LAA occlusion (LAAO) is generally discouraged. We report our single-center experience using a concomitant PFO for LAAO, thereby avoiding transseptal puncture.

01 diciembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Hybrid procedure of bilateral pulmonary artery banding and bilateral ductal stenting in an infant with aortic atresia and interrupted aortic arch

Daisuke Kobayashi MD1,*, Daniel R. Turner MD1, Ralph E. Delius MD2 andSanjeev Aggarwal MD1

We report an infant with aortic valve atresia, interrupted aortic arch, ventricular septal defect, confluent pulmonary arteries, bilateral arterial ducts, absent common carotid arteries, and anomalous coronary arteries arising from main pulmonary artery. Hybrid procedure consisting of bilateral pulmonary artery banding and bilateral arterial duct stenting was performed at 4 weeks of age. Hybrid procedure can be an alternative palliative approach in an infant with this complex cardiac anatomy. © 2014 Wiley Periodicals, Inc.

01 diciembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract

Qi-Ling Cao MD1, Damien Kenny MB, MD1, Daxin Zhou MD2, Wenzhi Pan MD2, Lihua Guan MD2, Junbo Ge MD, PhD2 andZiyad M. Hijazi MD, MPH1,*

Introduction: Balloon expandable transcatheter pulmonary valve systems are not applicable to the large majority of patients with chronic severe pulmonary regurgitation (PR) following surgical right ventricular outflow tract (RVOT) rehabilitation. This report describes the clinical use and short-term follow-up of a novel transcatheter self-expanding pulmonary valve system (Venus P Valve) for rehabilitation of the RVOT in patients with chronic severe PR.

01 diciembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. First-in-Man Study of the Low-Dose Paclitaxel Using the COBRA-P Drug-Eluting Coronary Stent System With a Novel Biodegradable Coating in De Novo Coronary Lesions

Daisaku Nakatani MD, PhD1, Katsuhisa Waseda MD, PhD1, Junya Ako MD, PhD1, Carlos Calderas MD2, Jose A. Condado MD3, Jose F. Condado MD3, Yasuhiro Honda MD1 andPeter J. Fitzgerald MD, PhD1,*

Objective: The aim of this first-in-man trial was to evaluate vessel response of two doses of the balloon expandable Cobra-P drug-eluting coronary stent (DES).

01 diciembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter

Bodo Cremers MD1, Stephanie Schmitmeier PhD2, Yvonne P. Clever MD1, Gary Gershony MD3, Ulrich Speck PhD4 andBruno Scheller MD1,*

Objective: Scoring balloons are particularly useful in the acute treatment of fibro-calcific, bifurcation and in-stent restenosis lesions but have not been shown to affect the restenosis rate. Conventional balloons coated with paclitaxel have recently been shown to reduce restenosis rates in certain lesion subsets, but are associated with suboptimal acute results. A novel paclitaxel-coated scoring balloon was developed to overcome these limitations.

01 octubre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Magnetic navigation facilitates percutaneous coronary intervention for complex lesions

Gurpreet S. Sandhu MD, PhD1,*, Saurabh Sanon MD1, David R. Holmes Jr. MD1, Rajiv Gulati MD, PhD1, Emmanouil S. Brilakis MD, PhD2, Ryan J. Lennon MS3 andCharanjit S. Rihal MD1

Background: We sought to determine the utility of a magnetic navigation system (MNS) in treating a variety of coronary artery lesions including those that could not be revascularized with standard percutaneous coronary intervention (PCI). MNS may add value in the treatment of tortuous arteries and bifurcation lesions; however its widespread adoption has lagged because of cost and a lack of clear advantage over conventional PCI. We performed a retrospective analysis to determine whether MNS improved procedural success for highly complex lesions.

01 octubre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Frequency and outcomes of aortocoronary dissection during percutaneous coronary intervention of chronic total occlusions

Deborah Shorrock1,2, Tesfaldet T. Michael MD, MPH1,2, Vishal Patel MD1,2, Anna Kotsia MD1,2, Bavana V. Rangan BDS, MPH1,2, Shuaib A. Abdullah MD1,2, Jerrold M. Grodin MD1,2, Avantika Banerjee MD1,2 andEmmanouil S. Brilakis MD, PhD1,2,*

Background: Aortocoronary dissection can complicate percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs).

01 noviembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Optical coherence tomography derived differences of plaque characteristics in coronary culprit lesions between type 2 diabetic patients with and without acute coronary syndrome

Sebastian Reith MD*, Simone Battermann, Rainer Hoffmann MD, Nikolaus Marx MD andMathias Burgmaier MD

Objective: To compare optical coherence tomography (OCT)-derived plaque characteristics of coronary target lesions between diabetic patients with acute coronary syndrome (ACS) versus stable angina pectoris (SAP).

01 noviembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Comparison of near-infrared spectroscopy and optical coherence tomography for detection of lipid

Taishi Yonetsu MD1, William Suh MD2, Farhad Abtahian MD, PhD1, Koji Kato MD, PhD1, Rocco Vergallo MD1, Soo-Joong Kim MD, PhD1,3, Haibo Jia MD, PhD1,4, Iris McNulty RN1, Hang Lee PhD5 andIk-Kyung Jang MD, PhD1,*

Objectives: To compare intracoronary near-infrared spectroscopy (NIRS) and optical coherence tomography (OCT) for the detection of lipid, to identify NIRS signals to differentiate superficial lipid, and to characterize the plaque with yellow block (YB) chemograms on NIRS.

01 noviembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent

Francisco Javier Toledano Delgado MD1,*, Manuel Pan Álvarez-Ossorio MD1, José Suárez de Lezo Cruz-Conde MD1, Francisco Mazuelos Bellido MD1, Miguel Ángel Romero Moreno MD1, Alfonso Medina Fernández-Aceytuno MD2, Javier Suárez de Lezo Herrerosde Tejada MD1, Soledad Ojeda Pineda MD1, José María Segura Saint-Gerons MD1 andDjordje Pavlovic MD1

Objectives: To compare strut coverage patterns between everolimus-eluting stent (EES) and first-generation drug-eluting stents (DES) at more than 12 months after successful implantation, using optical coherence tomography (OCT).

01 noviembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Low molecular weight dextran provides similar optical coherence tomography coronary imaging compared to radiographic contrast media

Kyle Frick MD, Tesfaldet T. Michael MD, MPH, Mohammed Alomar MD, Atif Mohammed MD, Bavana V. Rangan BDS, MPH, Shuaib Abdullah MD, Jerrold Grodin MD, Jeffrey L. Hastings MD, Subhash Banerjee MD andEmmanouil S. Brilakis MD, PhD

Background: Optical coherence tomography (OCT) coronary imaging requires displacement of red blood cells from the vessel lumen. This is usually accomplished using radiographic contrast. Low molecular weight dextran has low cost and is safe in low volumes. In the present study, we compared dextran with contrast for coronary OCT imaging.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.